Paris, 5 February 2008 - The French pharmaceutical group LFB and the French Rare Diseases Alliance, a collective of 179 associations of patients with rare diseases, signed a two-year agreement. This first agreement serves to confirm and structure relations built between the collective and LFB over nearly five years to ensure transparency and continuity... LFB is a French pharmaceutical group specialised in therapeutic proteins in the form of plasma-derived or biotechnology medicinal products... LFB's Press Release - Communiqué de Presse de LFB-Thursday, February 21, 2008
LFB and the French Rare Diseases Alliance, Partnership
Paris, 5 February 2008 - The French pharmaceutical group LFB and the French Rare Diseases Alliance, a collective of 179 associations of patients with rare diseases, signed a two-year agreement. This first agreement serves to confirm and structure relations built between the collective and LFB over nearly five years to ensure transparency and continuity... LFB is a French pharmaceutical group specialised in therapeutic proteins in the form of plasma-derived or biotechnology medicinal products... LFB's Press Release - Communiqué de Presse de LFB-
